Third- and second-generation oral contraceptives are associated with similar risk estimates for venous thromboembolism (Q33932536)

30 July 2017

1 reference

title

Third- and second-generation oral contraceptives are associated with similar risk estimates for venous thromboembolism (English)

1 reference

30 July 2017

main subject

venous thromboembolism

1 reference

Kaper RF

1 reference

30 July 2017

Norpoth T

series ordinal

1 reference

30 July 2017

Rekers H

series ordinal

1 reference

30 July 2017

language of work or name

1 reference

1 March 2000

1 reference

The European Journal of Contraception Reproductive Health Care

30 July 2017

published in

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

1-15

1 reference

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Classification and comparison of oral contraceptives containing new generation progestogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Could preferential prescribing and referral behaviour of physicians explain the elevated thrombosis risk found to be associated with third generation oral contraceptives?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Population-based study of risk of venous thromboembolism associated with various oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

The epidemiology of oral contraceptive use: a critical review of the studies on oral contraceptives and the health of young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus database

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

The differential risk of oral contraceptives: the impact of full exposure history

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Third-generation oral contraceptive and deep venous thrombosis: From epidemiologic controversy to new insight in coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Newer oral contraceptives and the risk of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Third-generation oral contraceptives and low free protein S as a risk for venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Oral contraceptives and mortality from venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Mortality from venous thromboembolism among young women in Europe: no evidence for any effect of third generation oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Admission for and mortality from primary venous thromboembolism in women of fertile age in Denmark, 1977-95

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third-generation oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Third-generation oral contraceptives and venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

Use of "off-label" and unlicensed drugs in paediatric intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

The risk of venous thromboembolism in users of postcoital contraceptive pills

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500371

10.1080/13625180008500371

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference